PRDM16 determines specification of ventricular cardiomyocytes by suppressing alternative cell fates.
Journal
Life science alliance
ISSN: 2575-1077
Titre abrégé: Life Sci Alliance
Pays: United States
ID NLM: 101728869
Informations de publication
Date de publication:
Dec 2024
Dec 2024
Historique:
received:
14
03
2024
revised:
06
09
2024
accepted:
09
09
2024
medline:
21
9
2024
pubmed:
21
9
2024
entrez:
20
9
2024
Statut:
epublish
Résumé
PRDM16 is a transcription factor with histone methyltransferase activity expressed at the earliest stages of cardiac development. Pathogenic mutations in humans lead to cardiomyopathy, conduction abnormalities, and heart failure. PRDM16 is specifically expressed in ventricular but not atrial cardiomyocytes, and its expression declines postnatally. Because in other tissues PRDM16 is best known for its role in binary cell fate decisions, we hypothesized a similar decision-making function in cardiomyocytes. Here, we demonstrated that cardiomyocyte-specific deletion of
Identifiants
pubmed: 39304345
pii: 7/12/e202402719
doi: 10.26508/lsa.202402719
pii:
doi:
Substances chimiques
Prdm16 protein, mouse
0
Transcription Factors
0
DNA-Binding Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 Van Wauwe et al.